Membership

RFP, CGN and CGA Opportunities

The Alliance is a community dedicated to accelerating excellence in healthcare performance through education and collaboration. To help achieve this, we collect information on research proposals and grants offered through other healthcare-related organizations.

Current postings:

  1. American Academy of Dermatology
  2. Radius Health, Inc.
  3. Genentech
  4. Bristol-Myers Squibb
  5. Sanofi Genzyme and Regeneron Alliance
  6. Boehringer Ingelheim Pharmaceuticals, Inc.

 

American Academy of Dermatology

The Academy bestows a number of prestigious awards to recognize the contributions of individuals to the specialty as well as offering various grants and scholarships to assist recipients in furthering their areas of study and broadening knowledge in the field of dermatology.

Program for Innovative Continuing Medical Education in Dermatology (PICMED)

The program was established to facilitate dermatologists' continuing education through support and development of innovative continuing medical education programs.

Available grants

  • Multi-year grant: Applicants may request up to $50,000 (direct costs only) for a two (2) year funding period.  2nd year funding will be contingent on 1st year milestones being met. 
  • Single-year grant: Applicants may request up to $10,000 (direct costs only) for a one (1) year project period. 

For more information regarding PICMED, please visit the AAD website.


    Radius Health, Inc.

    Radius Health is seeking proposals to close this independently defined healthcare gap to improve clinician knowledge of how to evaluate, diagnose, and treat patients with postmenopausal osteoporosis through independent medical education designed per well-referenced learner preferences.

    Single supported proposals for a dinner program at ASBMR 2017 will be considered with a maximum request not to exceed $100,000 (for the program, not including congress fees).


    Genentech

    Genentech posted a Call for Grant Notification (CGN) for Improving Knowledge in Emerging Areas in two different disease states in support of IME activities. In addition, the organization has a Scientific Research Project CGN (in multiple disease areas) for Improving Precision Care as a Catalyst for Promoting System-Level Improvements and a Fellowship CGN for Veterinary Pathology.


    Bristol-Myers Squibb

    Bristol-Myers Squibb accepts funding requests within the following therapeutic areas of interest. As areas of interest and funding consideration may change periodically, please consult this website frequently. Please note that international funding opportunities may differ.

    • Cardiovascular
    • Immunoscience
    • Oncology
    • Virology
    • Genetically Defined / Rare Diseases

    View Request for Proposals / for Education


    Sanofi Genzyme and Regeneron Alliance

    The Alliance (Sanofi Genzyme and Regeneron Pharmaceuticals) is seeking proposals to close the attached independently defined healthcare gaps, and provide education for health care providers on the problem of uncontrolled asthma. This education would be targeted to appropriate clinicians (e.g., Physicians [Allergists and Pulmonologists]) to optimize patient outcomes. The grant committee will consider independent medical education applications designed to close these gaps according to well-referenced learner preferences.


    Boehringer Ingelheim Pharmaceuticals, Inc.

    The intent of this Request for Educational Grant Applications (REGA) announcement is to notify experienced and eligible medical education providers that BIPI is interested in receiving applications for IME  activities pertinent to Mesothelioma and aligned to the specifications outlined in the downloadable Request for Proposal. 

    • Therapeutic Area: Oncology- Mesothelioma

      REGA Submission Deadline: Accepted on an ongoing basis. Review is prioritized based on date of receipt, program requirements and available budget.

      Download Request for Proposal